← board
AFMD
$0.18today0% from 52w high
Revenue
pre-revenue
Liquidity
—
Runway
—
Shares 1y
—
Overview
- Volume
- 0
- 52 Week Range
- $0.18 – $0.18
Pipeline · 0 trials · 0 upcoming
| Readout | Phase | Drug | Indication | Enroll | Status |
|---|---|---|---|---|---|
| No pipeline trials tracked. | |||||
Catalyst news & presentations · 0
- No catalyst news yet.
Approved drugs (0)
- none — clinical-stage
Capital structure — dilution & financing
Shares out: —
- none
🔒 Top holders — Pro
Institutional ownership + quarter-over-quarter accumulation/trimming.
Upgrade to ProWall St ratings
no consensus
- 2025-05-14HC Wainwright & Co.Buy → Neutral
- 2025-05-13Wells FargoOverweight → Equal-Weight
- 2025-05-13Leerink PartnersOutperform → Market Perform
- 2024-12-12Wells FargoOverweight
- 2024-12-10HC Wainwright & Co.Buy
- 2024-11-19Cantor FitzgeraldOverweight
Competitors
- none identified
Recent news
- none
Not financial advice. Data: ClinicalTrials.gov, SEC EDGAR, FINRA, Nasdaq, Yahoo.